Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | FGB | P02675 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.45 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.41 |
| ▸ | CFTR | P13569 | 1/20 | 0.40 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23900973 | 0.94 | CYP1A2 (0.42) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL23900983 | 0.91 | CYP1A2 (0.45) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL23900986 | 0.91 | CYP1A2 (0.45) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL17207898 | 0.90 | CYP1A2 (0.47) | MEN1KMT2ACYP1A2NPSR1CFTR | |
| SCHEMBL21662354 | 0.88 | MEN1 (0.45) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL17207357 | 0.87 | LMNA (0.51) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL414309 | 0.86 | NPSR1 (0.52) | CYP1A2NPSR1CFTRGOPCCYP2C19 | |
| SCHEMBL23900865 | 0.84 | MEN1 (0.46) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL15998808 | 0.84 | ESR1 (0.45) | LMNAMEN1KMT2AALDH1A1FGB | |
| SCHEMBL17207360 | 0.84 | LMNA (0.45) | LMNAMEN1KMT2AALDH1A1FGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210309595-A1 | COMPOSITION FOR FORMING OPTICAL COMPONENT, OPTICAL COMPONENT, COMPOUND, AND RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-10-07 | — | — | US | disclosed |
| EP-3831882-A1 | OPTICAL COMPONENT-FORMING COMPOSITION, OPTICAL COMPONENT, COMPOUND, AND RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020027206-A1 | OPTICAL COMPONENT-FORMING COMPOSITION, OPTICAL COMPONENT, COMPOUND, AND RESIN | 三菱瓦斯化学株式会社 | 2020-02-06 | — | — | WO | disclosed |
| US-9274426-B2 | Antireflective coating compositions and processes thereof | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2016-03-01 | — | — | US | disclosed |
| US-20150309403-A1 | ANTIREFLECTIVE COATING COMPOSITIONS AND PROCESSES THEREOF | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150309410-A1 | ANTIREFLECTIVE COATING COMPOSITIONS AND PROCESSES THEREOF | AZ ELECTRONIC MATERIALS S.À R.L. (LU) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309595-A1 | COMPOSITION FOR FORMING OPTICAL COMPONENT, OPTICAL COMPONENT, COMPOUND, AND RESIN | DCXR, MLX, TXN | LMNA 544/4885MEN1 4211/4885KMT2A 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.